From the Guidelines
For Pasteurella multocida bacteremia in patients with penicillin allergy, doxycycline (100 mg orally twice daily) or a fluoroquinolone such as ciprofloxacin (400 mg IV twice daily or 500-750 mg orally twice daily) is recommended for 10-14 days. This recommendation is based on the guidelines for the diagnosis and management of skin and soft-tissue infections, which suggest that patients with previous severe reactions can receive oral or intravenous doxycycline, trimethoprim-sulfamethoxazole, or a fluoroquinolone plus clindamycin 1.
Key Considerations
- The choice between these options depends on the severity of the infection, patient factors, and local resistance patterns.
- For severe infections, initial IV therapy followed by oral step-down therapy is appropriate.
- In cases of serious penicillin allergy, carbapenems should be avoided due to potential cross-reactivity.
- Pasteurella multocida is typically susceptible to these alternative antibiotics, though fluoroquinolones may have slightly lower efficacy compared to beta-lactams.
Treatment Duration and Monitoring
- Treatment duration may need extension if there are complications such as endocarditis or osteomyelitis.
- Clinical improvement should be evident within 48-72 hours of appropriate therapy, and follow-up blood cultures may be necessary to confirm clearance of bacteremia.
- Trimethoprim-sulfamethoxazole (TMP-SMX) is another alternative (5 mg/kg of the trimethoprim component IV or orally twice daily) 1.
From the Research
Treatment Options for Pasteurella Multicida Bacteremia
- For patients with penicillin allergy, alternative treatment options include:
- The duration of treatment for Pasteurella multicida bacteremia is:
Considerations for Penicillin Allergy
- Patients with penicillin allergy may be treated with alternative antibiotics, such as those listed above
- The choice of antibiotic should be based on the severity of the infection and the patient's medical history